Desai Neil

EXECUTIVE CHAIRMAN, DirectorAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Aug 5, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$57K
Net Open-Market Flow
-$57K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 5, 2024Sell(S)6K$1.34$8K1.2M
Aug 2, 2024Sell(S)19K$1.41$27K1.2M
Aug 1, 2024Sell(S)15K$1.50$23K1.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-020784) within minutes of acceptance. Every field above traces to the original document. Verify it directly: